1. Home
  2. FRES

FRES

Fresh2 Group Limited

Logo Fresh2 Group Limited

Health Care

Medical Specialities

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Founded: 2010 Country:
British Virgin Islands
British Virgin Islands
Employees: N/A City: N/A
Market Cap: 9.1M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 75.0
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.29 EPS Growth: N/A
52 Week Low/High: $0.30 - $9.17 Next Earning Date: 06-17-2024
Revenue: $2,345,304 Revenue Growth: -4.44%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: